Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine

NCT00888680 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No patients enrolled. Delay due to optimisation of drug product formulation.

Conditions

Migraine

Interventions

DRUG: BGC20-1531
DRUG: Lactose

Sponsor

Boston Scientific Corporation